DOI: 10.1016/s0145-2126(00)00053-9. Parameters involved in the recognition of fresh human leukemic blasts by tumor-specific cytolytic T cell clones: a model study

Parameters involved in the recognition of fresh human leukemic blasts by tumor-specific cytolytic T cell clones: a model study

10.1016/s0145-2126(00)00053-9

Crossref journal-article

Elsevier BV

Leukemia Research (78)

Bibliography

Chambost, H., Collette, Y., Dutartre, H., Thuret, I., & Olive, D. (2000). Parameters involved in the recognition of fresh human leukemic blasts by tumor-specific cytolytic T cell clones: a model study. Leukemia Research, 24(10), 823â830.

Authors 5

Hervé Chambost (first)
Yves Collette (additional)
Hélène Dutartre (additional)
Isabelle Thuret (additional)
Daniel Olive (additional)

References 49 Referenced 4

10.1056/NEJM197905103001902 / New Engl. J. Med. / Antileukemic effect of graft versus host disease in human recipients of allogeneic marrow grafts by Weiden (1979)
{'issue': 'suppl 1', 'key': '10.1016/S0145-2126(00)00053-9_BIB2', 'first-page': '76', 'article-title': 'Immunotherapy of leukemia', 'volume': '6', 'author': 'Brenner', 'year': '1992', 'journal-title': 'Leukemia'} / Leukemia / Immunotherapy of leukemia by Brenner (1992)
10.1097/00001622-199603000-00003 / Curr. Opin. Oncol. / The graft-versus-leukemia effect by Barrett (1996)
10.3109/10428199009042467 / Leuk. Lymph. / Induction and persistence of complete remission in a resistant acute myeloid leukemia patient after treatment with recombinant interleukin-2 by Foa (1990)
10.1182/blood.V78.9.2182.2182 / Blood / High-dose recombinant interleukin-2 and acute myeloid leukemias in relapse by Maraninchi (1991)
{'key': '10.1016/S0145-2126(00)00053-9_BIB6', 'first-page': '283', 'article-title': 'Immunotherapy with interleukin 2 with or without lymphokine-activated killer cells after autologous bone marrow transplantation for malignant lymphoma: a feasibility trial', 'volume': '16', 'author': 'Benyunes', 'year': '1995', 'journal-title': 'Bone Marrow Transpl.'} / Bone Marrow Transpl. / Immunotherapy with interleukin 2 with or without lymphokine-activated killer cells after autologous bone marrow transplantation for malignant lymphoma: a feasibility trial by Benyunes (1995)
10.1016/S0140-6736(95)90978-8 / Lancet / Impairement of leukemia-free survival by addition of interleukin-2-receptor antibody to standard graft-versus-host prophylaxis by Blaise (1995)
10.1182/blood.V86.5.2041.bloodjournal8652041 / Blood / Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients by Kolb (1995)
10.1182/blood.V86.4.1261.bloodjournal8641261 / Blood / Adoptive immunotherapy evaluating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia response from graft-versus-host disease by Mackinnon (1995)
10.1182/blood.V67.3.722.722 / Blood / Characterization of natural killer cells with antileukemic activity after allogeneic bone marrow transplantation by Hercend (1986)
{'key': '10.1016/S0145-2126(00)00053-9_BIB11', 'first-page': '53', 'article-title': 'Bone marrow transplantation for patients with chronic myeloid leukemia: T cell depletion with Campath-1 reduces the incidence of graft versus host disease but may increase the risk of leukemia relapse', 'volume': '1', 'author': 'Apperley', 'year': '1988', 'journal-title': 'Bone Marrow Transpl.'} / Bone Marrow Transpl. / Bone marrow transplantation for patients with chronic myeloid leukemia: T cell depletion with Campath-1 reduces the incidence of graft versus host disease but may increase the risk of leukemia relapse by Apperley (1988)
10.4049/jimmunol.138.8.2718 / J. Immunol. / Induction of NK cell activity against fresh human leukemia in culture with interleukin-2 by Lotzova (1987)
10.1182/blood.V68.4.938.938 / Blood / Cytotoxicity of interleukin-2 activated lymphocytes for leukemic and lymphoma cells by Oshimi (1986)
10.1182/blood.V73.8.2077.2077 / Blood / TCR γδ bearing lymphocyte clones with lymphokine-activated killer against autologous leukemic cells by Bensussan (1989)
10.1182/blood.V75.10.2005.2005 / Blood / Specific recognition of human leukemic cells by allogeneic T cells: II. Evidence for HLA-D restricted determinants on leukemic cells that are crossreactive with determinants present on unrelated nonleukemic cells by Sosman (1990)
10.1182/blood.V83.4.1060.1060 / Blood / Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemia cells by cytotoxic T-cell clones by van der Harst (1995)
Faber LM, van der Hoever, Goulmy E, Hooftman-den Otter AL, Luxenburg-Heijs SAP, Willemze R, Falkenburg JHF. Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic lymphocytes. J Clin Invest 1995;96:877. (10.1172/JCI118134)
10.1126/science.7667640 / Science / Human H-Y: a male-specific histocompatibility antigen dervied from the SMCY protein by Wang (1995)
10.1126/science.279.5353.1054 / Science / The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism by Den Haan (1998)
10.1084/jem.183.3.725 / J. Exp. Med. / Human tumor antigens recognized by T lymphocytes by Boon (1996)
10.1182/blood.V81.5.1369.1369 / Blood / Human cd4+ lymphocytes specifically recognize a peptide representing the fusion region of the hybrid protein PML-RARa present in acute promyelocytic cells by Gambacorti-Passerini (1993)
10.1182/blood.V85.10.2680.bloodjournal85102680 / Blood / Specific binding of leukemia oncogene fusion protein peptides to HLA class I molecules by Bocchia (1995)
{'key': '10.1016/S0145-2126(00)00053-9_BIB23', 'first-page': '1344', 'article-title': 'Recognition of peptides corresponding to the joining region of p210 BCR-ABL protein by human T cells', 'volume': '9', 'author': 'Ten Bosch', 'year': '1995', 'journal-title': 'Leukemia'} / Leukemia / Recognition of peptides corresponding to the joining region of p210 BCR-ABL protein by human T cells by Ten Bosch (1995)
10.1172/JCI3126 / J. Clin. Invest. / Cytotoxic T cell response against the chimeric ETV6-AML1 protein in childhood acute lymphoblastic leukemia by Yotdna (1998)
10.1182/blood.V91.3.977 / Blood / Dendritic cells stimulate the expansion of bcr-abl specific CD8+ T cells with cytotoxic activity against leukemic cells from patients with chronic myelogenous leukemia by Nieda (1998)
10.1093/intimm/9.5.791 / Int. Immunol. / Cytotoxic T lymphocytes derived from bone marrow mononuclear cells of multiple myeloma patients recognize an underglycosylated form of MUC1 mucin by Noto (1997)
10.1182/blood.V89.6.1978 / Blood / Isolation of Epstein–Barr virus specific cytotoxic T lymphocytes that lyse Reed–Sternberg cells: implications for immune-mediated therapy for EBV+ Hodgkin’s disease by Sing (1997)
10.1126/science.1840703 / Science / A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma by van den Bruggen (1991)
10.1002/ijc.2910520528 / Int. J. Cancer / Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors by Brasseur (1992)
10.1007/BF01246677 / Immunogenetics / Structure, chromosomal localization and expression of 12 genes of the MAGE family by de Plaen (1994)
10.1084/jem.176.5.1453 / J. Exp. Med. / A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by CTL directed against tumor antigen MZ2-E tumors by Traversari (1992)
10.1002/eji.1830241218 / Eur. J. Immunol. / A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3 by van den Bruggen (1994)
Chambost H, Brasseur F, de Plaen E, Stoppa Am, Baume D, Mannoni P, Boon T, Maraninchi D, Olive D. A tumour-associated antigen expression in human haematological malignancies. Br J Haematol 1993;84:524. (10.1111/j.1365-2141.1993.tb03111.x)
{'key': '10.1016/S0145-2126(00)00053-9_BIB34', 'first-page': '95', 'article-title': 'Expression of the MAGE gene family in human lymphocytic leukemia', 'volume': '41', 'author': 'Schichijo', 'year': '1995', 'journal-title': 'Cancer Immunol. Immunother.'} / Cancer Immunol. Immunother. / Expression of the MAGE gene family in human lymphocytic leukemia by Schichijo (1995)
{'key': '10.1016/S0145-2126(00)00053-9_BIB35', 'first-page': '1156', 'article-title': 'Genes encoding tumor-specific antigens are expressed in human myeloma cells', 'volume': '94', 'author': 'van Baren', 'year': '1999', 'journal-title': 'Blood'} / Blood / Genes encoding tumor-specific antigens are expressed in human myeloma cells by van Baren (1999)
Chambost H, van Baren N, Brasseur F, Godelaine D, Theate I, Spagnoli GC, Xerri L, Plumas J, Michel G, Coulie PG, Olive D. Expression of gene MAGE4-A4 in Reed Sternberg cells. Blood 2000;95(11):(in press).
10.1007/BF00185107 / Immunogenetics / Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes by Traversari (1992)
10.1007/BF00375376 / Immunogenetics / Genes regulating HLA class I antigen expression in T-B lymphocyte by Salter (1985)
10.1084/jem.179.3.921 / J. Exp. Med. / Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes by Gaugler (1994)
10.1016/0022-1759(89)90397-9 / J. Immunol. Methods / Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill by Hansen (1989)
10.1084/jem.152.5.1184 / J. Exp. Med. / Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis by Boon (1980)
10.1002/(SICI)1097-0215(19990118)80:2<219::AID-IJC10>3.0.CO;2-S / Int. J. Cancer / Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA A1 by Marchand (1999)
10.1084/jem.189.6.895 / J. Exp. Med. / Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3 by Valmori (1999)
Restifo NP, Marincola FM, Kawakami Y, Taubenberger Y, Tannelli JR, Rosenberg SA. Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy. JNCI:1996; 88:100. (10.1093/jnci/88.2.100)
10.1038/sj.bmt.1700778 / Bone Marrow Transpl. / Immune escape from a graft-versus-leukemia effect may play a role in the relapse of myeloid leukemias following allogeneic bone marrow transplantation by Dermine (1996)
{'issue': 'Suppl 2', 'key': '10.1016/S0145-2126(00)00053-9_BIB46', 'first-page': 'S83', 'article-title': 'MAGE-1 expression threshold for the lysis of melanoma cell lines by a specific cytotoxic T lymphocyte', 'volume': '7', 'author': 'Lethe', 'year': '1997', 'journal-title': 'Melanoma Res.'} / Melanoma Res. / MAGE-1 expression threshold for the lysis of melanoma cell lines by a specific cytotoxic T lymphocyte by Lethe (1997)
10.1073/pnas.93.14.7149 / PNAS / The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation by De Smet (1996)
10.1111/j.1349-7006.1996.tb00288.x / Jpn. J. Cancer Res. / Induction of MAGE genes in lymphoid cells by demethylating agent 5-aza-2′-deoxycytidine by Schichijo (1996)
{'key': '10.1016/S0145-2126(00)00053-9_BIB49', 'first-page': '642', 'article-title': 'Variability of the alloreactive T-cell response to human leukemic blasts', 'volume': '8', 'author': 'Delain', 'year': '1994', 'journal-title': 'Leukemia'} / Leukemia / Variability of the alloreactive T-cell response to human leukemic blasts by Delain (1994)

Dates

Type	When
Created	23 years, 1 month ago (July 25, 2002, 10:21 a.m.)
Deposited	2 years, 4 months ago (April 9, 2023, 2:10 a.m.)
Indexed	2 years, 4 months ago (April 9, 2023, 2:40 a.m.)
Issued	24 years, 10 months ago (Oct. 1, 2000)
Published	24 years, 10 months ago (Oct. 1, 2000)
Published Print	24 years, 10 months ago (Oct. 1, 2000)

Funders 0

None

BibTeX

@article{Chambost_2000, title={Parameters involved in the recognition of fresh human leukemic blasts by tumor-specific cytolytic T cell clones: a model study}, volume={24}, ISSN={0145-2126}, url={http://dx.doi.org/10.1016/s0145-2126(00)00053-9}, DOI={10.1016/s0145-2126(00)00053-9}, number={10}, journal={Leukemia Research}, publisher={Elsevier BV}, author={Chambost, Hervé and Collette, Yves and Dutartre, Hélène and Thuret, Isabelle and Olive, Daniel}, year={2000}, month=oct, pages={823–830} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2023,
        4,
        9
      ]
    ],
    "date-time": "2023-04-09T06:40:14Z",
    "timestamp": 1681022414122
  },
  "reference-count": 49,
  "publisher": "Elsevier BV",
  "issue": "10",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2000,
            10,
            1
          ]
        ],
        "date-time": "2000-10-01T00:00:00Z",
        "timestamp": 970358400000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2000,
        10
      ]
    ]
  },
  "DOI": "10.1016/s0145-2126(00)00053-9",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2002,
        7,
        25
      ]
    ],
    "date-time": "2002-07-25T14:21:08Z",
    "timestamp": 1027606868000
  },
  "page": "823-830",
  "source": "Crossref",
  "is-referenced-by-count": 4,
  "title": "Parameters involved in the recognition of fresh human leukemic blasts by tumor-specific cytolytic T cell clones: a model study",
  "prefix": "10.1016",
  "volume": "24",
  "author": [
    {
      "given": "Herv\u00e9",
      "family": "Chambost",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Yves",
      "family": "Collette",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "H\u00e9l\u00e8ne",
      "family": "Dutartre",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Isabelle",
      "family": "Thuret",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Daniel",
      "family": "Olive",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "78",
  "reference": [
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB1",
      "doi-asserted-by": "crossref",
      "first-page": "1068",
      "DOI": "10.1056/NEJM197905103001902",
      "article-title": "Antileukemic effect of graft versus host disease in human recipients of allogeneic marrow grafts",
      "volume": "300",
      "author": "Weiden",
      "year": "1979",
      "journal-title": "New Engl. J. Med."
    },
    {
      "issue": "suppl 1",
      "key": "10.1016/S0145-2126(00)00053-9_BIB2",
      "first-page": "76",
      "article-title": "Immunotherapy of leukemia",
      "volume": "6",
      "author": "Brenner",
      "year": "1992",
      "journal-title": "Leukemia"
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB3",
      "doi-asserted-by": "crossref",
      "first-page": "89",
      "DOI": "10.1097/00001622-199603000-00003",
      "article-title": "The graft-versus-leukemia effect",
      "volume": "8",
      "author": "Barrett",
      "year": "1996",
      "journal-title": "Curr. Opin. Oncol."
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB4",
      "doi-asserted-by": "crossref",
      "first-page": "113",
      "DOI": "10.3109/10428199009042467",
      "article-title": "Induction and persistence of complete remission in a resistant acute myeloid leukemia patient after treatment with recombinant interleukin-2",
      "volume": "1",
      "author": "Foa",
      "year": "1990",
      "journal-title": "Leuk. Lymph."
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB5",
      "doi-asserted-by": "crossref",
      "first-page": "2182",
      "DOI": "10.1182/blood.V78.9.2182.2182",
      "article-title": "High-dose recombinant interleukin-2 and acute myeloid leukemias in relapse",
      "volume": "78",
      "author": "Maraninchi",
      "year": "1991",
      "journal-title": "Blood"
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB6",
      "first-page": "283",
      "article-title": "Immunotherapy with interleukin 2 with or without lymphokine-activated killer cells after autologous bone marrow transplantation for malignant lymphoma: a feasibility trial",
      "volume": "16",
      "author": "Benyunes",
      "year": "1995",
      "journal-title": "Bone Marrow Transpl."
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB7",
      "doi-asserted-by": "crossref",
      "first-page": "1144",
      "DOI": "10.1016/S0140-6736(95)90978-8",
      "article-title": "Impairement of leukemia-free survival by addition of interleukin-2-receptor antibody to standard graft-versus-host prophylaxis",
      "volume": "345, 8958",
      "author": "Blaise",
      "year": "1995",
      "journal-title": "Lancet"
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB8",
      "doi-asserted-by": "crossref",
      "first-page": "2041",
      "DOI": "10.1182/blood.V86.5.2041.bloodjournal8652041",
      "article-title": "Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients",
      "volume": "86",
      "author": "Kolb",
      "year": "1995",
      "journal-title": "Blood"
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB9",
      "doi-asserted-by": "crossref",
      "first-page": "1261",
      "DOI": "10.1182/blood.V86.4.1261.bloodjournal8641261",
      "article-title": "Adoptive immunotherapy evaluating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia response from graft-versus-host disease",
      "volume": "86",
      "author": "Mackinnon",
      "year": "1995",
      "journal-title": "Blood"
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB10",
      "doi-asserted-by": "crossref",
      "first-page": "722",
      "DOI": "10.1182/blood.V67.3.722.722",
      "article-title": "Characterization of natural killer cells with antileukemic activity after allogeneic bone marrow transplantation",
      "volume": "67",
      "author": "Hercend",
      "year": "1986",
      "journal-title": "Blood"
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB11",
      "first-page": "53",
      "article-title": "Bone marrow transplantation for patients with chronic myeloid leukemia: T cell depletion with Campath-1 reduces the incidence of graft versus host disease but may increase the risk of leukemia relapse",
      "volume": "1",
      "author": "Apperley",
      "year": "1988",
      "journal-title": "Bone Marrow Transpl."
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB12",
      "doi-asserted-by": "crossref",
      "first-page": "2718",
      "DOI": "10.4049/jimmunol.138.8.2718",
      "article-title": "Induction of NK cell activity against fresh human leukemia in culture with interleukin-2",
      "volume": "138",
      "author": "Lotzova",
      "year": "1987",
      "journal-title": "J. Immunol."
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB13",
      "doi-asserted-by": "crossref",
      "first-page": "938",
      "DOI": "10.1182/blood.V68.4.938.938",
      "article-title": "Cytotoxicity of interleukin-2 activated lymphocytes for leukemic and lymphoma cells",
      "volume": "68",
      "author": "Oshimi",
      "year": "1986",
      "journal-title": "Blood"
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB14",
      "doi-asserted-by": "crossref",
      "first-page": "2077",
      "DOI": "10.1182/blood.V73.8.2077.2077",
      "article-title": "TCR \u03b3\u03b4 bearing lymphocyte clones with lymphokine-activated killer against autologous leukemic cells",
      "volume": "73",
      "author": "Bensussan",
      "year": "1989",
      "journal-title": "Blood"
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB15",
      "doi-asserted-by": "crossref",
      "first-page": "2005",
      "DOI": "10.1182/blood.V75.10.2005.2005",
      "article-title": "Specific recognition of human leukemic cells by allogeneic T cells: II. Evidence for HLA-D restricted determinants on leukemic cells that are crossreactive with determinants present on unrelated nonleukemic cells",
      "volume": "75",
      "author": "Sosman",
      "year": "1990",
      "journal-title": "Blood"
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB16",
      "doi-asserted-by": "crossref",
      "first-page": "1060",
      "DOI": "10.1182/blood.V83.4.1060.1060",
      "article-title": "Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemia cells by cytotoxic T-cell clones",
      "volume": "83",
      "author": "van der Harst",
      "year": "1995",
      "journal-title": "Blood"
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB17",
      "doi-asserted-by": "crossref",
      "unstructured": "Faber LM, van der Hoever, Goulmy E, Hooftman-den Otter AL, Luxenburg-Heijs SAP, Willemze R, Falkenburg JHF. Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic lymphocytes. J Clin Invest 1995;96:877.",
      "DOI": "10.1172/JCI118134"
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB18",
      "doi-asserted-by": "crossref",
      "first-page": "1588",
      "DOI": "10.1126/science.7667640",
      "article-title": "Human H-Y: a male-specific histocompatibility antigen dervied from the SMCY protein",
      "volume": "269",
      "author": "Wang",
      "year": "1995",
      "journal-title": "Science"
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB19",
      "doi-asserted-by": "crossref",
      "first-page": "1054",
      "DOI": "10.1126/science.279.5353.1054",
      "article-title": "The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism",
      "volume": "279",
      "author": "Den Haan",
      "year": "1998",
      "journal-title": "Science"
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB20",
      "doi-asserted-by": "crossref",
      "first-page": "725",
      "DOI": "10.1084/jem.183.3.725",
      "article-title": "Human tumor antigens recognized by T lymphocytes",
      "volume": "183",
      "author": "Boon",
      "year": "1996",
      "journal-title": "J. Exp. Med."
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB21",
      "doi-asserted-by": "crossref",
      "first-page": "1369",
      "DOI": "10.1182/blood.V81.5.1369.1369",
      "article-title": "Human cd4+ lymphocytes specifically recognize a peptide representing the fusion region of the hybrid protein PML-RARa present in acute promyelocytic cells",
      "volume": "81",
      "author": "Gambacorti-Passerini",
      "year": "1993",
      "journal-title": "Blood"
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB22",
      "doi-asserted-by": "crossref",
      "first-page": "2680",
      "DOI": "10.1182/blood.V85.10.2680.bloodjournal85102680",
      "article-title": "Specific binding of leukemia oncogene fusion protein peptides to HLA class I molecules",
      "volume": "85",
      "author": "Bocchia",
      "year": "1995",
      "journal-title": "Blood"
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB23",
      "first-page": "1344",
      "article-title": "Recognition of peptides corresponding to the joining region of p210 BCR-ABL protein by human T cells",
      "volume": "9",
      "author": "Ten Bosch",
      "year": "1995",
      "journal-title": "Leukemia"
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB24",
      "doi-asserted-by": "crossref",
      "first-page": "455",
      "DOI": "10.1172/JCI3126",
      "article-title": "Cytotoxic T cell response against the chimeric ETV6-AML1 protein in childhood acute lymphoblastic leukemia",
      "volume": "102",
      "author": "Yotdna",
      "year": "1998",
      "journal-title": "J. Clin. Invest."
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB25",
      "doi-asserted-by": "crossref",
      "first-page": "977",
      "DOI": "10.1182/blood.V91.3.977",
      "article-title": "Dendritic cells stimulate the expansion of bcr-abl specific CD8+ T cells with cytotoxic activity against leukemic cells from patients with chronic myelogenous leukemia",
      "volume": "91",
      "author": "Nieda",
      "year": "1998",
      "journal-title": "Blood"
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB26",
      "doi-asserted-by": "crossref",
      "first-page": "791",
      "DOI": "10.1093/intimm/9.5.791",
      "article-title": "Cytotoxic T lymphocytes derived from bone marrow mononuclear cells of multiple myeloma patients recognize an underglycosylated form of MUC1 mucin",
      "volume": "9",
      "author": "Noto",
      "year": "1997",
      "journal-title": "Int. Immunol."
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB27",
      "doi-asserted-by": "crossref",
      "first-page": "1978",
      "DOI": "10.1182/blood.V89.6.1978",
      "article-title": "Isolation of Epstein\u2013Barr virus specific cytotoxic T lymphocytes that lyse Reed\u2013Sternberg cells: implications for immune-mediated therapy for EBV+ Hodgkin\u2019s disease",
      "volume": "89",
      "author": "Sing",
      "year": "1997",
      "journal-title": "Blood"
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB28",
      "doi-asserted-by": "crossref",
      "first-page": "1643",
      "DOI": "10.1126/science.1840703",
      "article-title": "A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma",
      "volume": "254",
      "author": "van den Bruggen",
      "year": "1991",
      "journal-title": "Science"
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB29",
      "doi-asserted-by": "crossref",
      "first-page": "839",
      "DOI": "10.1002/ijc.2910520528",
      "article-title": "Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors",
      "volume": "52",
      "author": "Brasseur",
      "year": "1992",
      "journal-title": "Int. J. Cancer"
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB30",
      "doi-asserted-by": "crossref",
      "first-page": "360",
      "DOI": "10.1007/BF01246677",
      "article-title": "Structure, chromosomal localization and expression of 12 genes of the MAGE family",
      "volume": "40",
      "author": "de Plaen",
      "year": "1994",
      "journal-title": "Immunogenetics"
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB31",
      "doi-asserted-by": "crossref",
      "first-page": "1453",
      "DOI": "10.1084/jem.176.5.1453",
      "article-title": "A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by CTL directed against tumor antigen MZ2-E tumors",
      "volume": "176",
      "author": "Traversari",
      "year": "1992",
      "journal-title": "J. Exp. Med."
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB32",
      "doi-asserted-by": "crossref",
      "first-page": "3038",
      "DOI": "10.1002/eji.1830241218",
      "article-title": "A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3",
      "volume": "24",
      "author": "van den Bruggen",
      "year": "1994",
      "journal-title": "Eur. J. Immunol."
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB33",
      "doi-asserted-by": "crossref",
      "unstructured": "Chambost H, Brasseur F, de Plaen E, Stoppa Am, Baume D, Mannoni P, Boon T, Maraninchi D, Olive D. A tumour-associated antigen expression in human haematological malignancies. Br J Haematol 1993;84:524.",
      "DOI": "10.1111/j.1365-2141.1993.tb03111.x"
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB34",
      "first-page": "95",
      "article-title": "Expression of the MAGE gene family in human lymphocytic leukemia",
      "volume": "41",
      "author": "Schichijo",
      "year": "1995",
      "journal-title": "Cancer Immunol. Immunother."
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB35",
      "first-page": "1156",
      "article-title": "Genes encoding tumor-specific antigens are expressed in human myeloma cells",
      "volume": "94",
      "author": "van Baren",
      "year": "1999",
      "journal-title": "Blood"
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB36",
      "unstructured": "Chambost H, van Baren N, Brasseur F, Godelaine D, Theate I, Spagnoli GC, Xerri L, Plumas J, Michel G, Coulie PG, Olive D. Expression of gene MAGE4-A4 in Reed Sternberg cells. Blood 2000;95(11):(in press)."
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB37",
      "doi-asserted-by": "crossref",
      "first-page": "145",
      "DOI": "10.1007/BF00185107",
      "article-title": "Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes",
      "volume": "35",
      "author": "Traversari",
      "year": "1992",
      "journal-title": "Immunogenetics"
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB38",
      "doi-asserted-by": "crossref",
      "first-page": "235",
      "DOI": "10.1007/BF00375376",
      "article-title": "Genes regulating HLA class I antigen expression in T-B lymphocyte",
      "volume": "21",
      "author": "Salter",
      "year": "1985",
      "journal-title": "Immunogenetics"
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB39",
      "doi-asserted-by": "crossref",
      "first-page": "921",
      "DOI": "10.1084/jem.179.3.921",
      "article-title": "Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes",
      "volume": "179",
      "author": "Gaugler",
      "year": "1994",
      "journal-title": "J. Exp. Med."
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB40",
      "doi-asserted-by": "crossref",
      "first-page": "203",
      "DOI": "10.1016/0022-1759(89)90397-9",
      "article-title": "Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill",
      "volume": "119",
      "author": "Hansen",
      "year": "1989",
      "journal-title": "J. Immunol. Methods"
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB41",
      "doi-asserted-by": "crossref",
      "first-page": "1184",
      "DOI": "10.1084/jem.152.5.1184",
      "article-title": "Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis",
      "volume": "152",
      "author": "Boon",
      "year": "1980",
      "journal-title": "J. Exp. Med."
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB42",
      "doi-asserted-by": "crossref",
      "first-page": "219",
      "DOI": "10.1002/(SICI)1097-0215(19990118)80:2<219::AID-IJC10>3.0.CO;2-S",
      "article-title": "Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA A1",
      "volume": "80",
      "author": "Marchand",
      "year": "1999",
      "journal-title": "Int. J. Cancer"
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB43",
      "doi-asserted-by": "crossref",
      "first-page": "895",
      "DOI": "10.1084/jem.189.6.895",
      "article-title": "Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3",
      "volume": "189",
      "author": "Valmori",
      "year": "1999",
      "journal-title": "J. Exp. Med."
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB44",
      "doi-asserted-by": "crossref",
      "unstructured": "Restifo NP, Marincola FM, Kawakami Y, Taubenberger Y, Tannelli JR, Rosenberg SA. Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy. JNCI:1996; 88:100.",
      "DOI": "10.1093/jnci/88.2.100"
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB45",
      "doi-asserted-by": "crossref",
      "first-page": "989",
      "DOI": "10.1038/sj.bmt.1700778",
      "article-title": "Immune escape from a graft-versus-leukemia effect may play a role in the relapse of myeloid leukemias following allogeneic bone marrow transplantation",
      "volume": "19",
      "author": "Dermine",
      "year": "1996",
      "journal-title": "Bone Marrow Transpl."
    },
    {
      "issue": "Suppl 2",
      "key": "10.1016/S0145-2126(00)00053-9_BIB46",
      "first-page": "S83",
      "article-title": "MAGE-1 expression threshold for the lysis of melanoma cell lines by a specific cytotoxic T lymphocyte",
      "volume": "7",
      "author": "Lethe",
      "year": "1997",
      "journal-title": "Melanoma Res."
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB47",
      "doi-asserted-by": "crossref",
      "first-page": "7149",
      "DOI": "10.1073/pnas.93.14.7149",
      "article-title": "The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation",
      "volume": "93",
      "author": "De Smet",
      "year": "1996",
      "journal-title": "PNAS"
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB48",
      "doi-asserted-by": "crossref",
      "first-page": "751",
      "DOI": "10.1111/j.1349-7006.1996.tb00288.x",
      "article-title": "Induction of MAGE genes in lymphoid cells by demethylating agent 5-aza-2\u2032-deoxycytidine",
      "volume": "87",
      "author": "Schichijo",
      "year": "1996",
      "journal-title": "Jpn. J. Cancer Res."
    },
    {
      "key": "10.1016/S0145-2126(00)00053-9_BIB49",
      "first-page": "642",
      "article-title": "Variability of the alloreactive T-cell response to human leukemic blasts",
      "volume": "8",
      "author": "Delain",
      "year": "1994",
      "journal-title": "Leukemia"
    }
  ],
  "container-title": "Leukemia Research",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0145212600000539?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0145212600000539?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2023,
        4,
        9
      ]
    ],
    "date-time": "2023-04-09T06:10:53Z",
    "timestamp": 1681020653000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0145212600000539"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2000,
        10
      ]
    ]
  },
  "references-count": 49,
  "journal-issue": {
    "issue": "10",
    "published-print": {
      "date-parts": [
        [
          2000,
          10
        ]
      ]
    }
  },
  "alternative-id": [
    "S0145212600000539"
  ],
  "URL": "http://dx.doi.org/10.1016/S0145-2126(00)00053-9",
  "relation": {},
  "ISSN": [
    "0145-2126"
  ],
  "subject": [],
  "container-title-short": "Leukemia Research",
  "published": {
    "date-parts": [
      [
        2000,
        10
      ]
    ]
  }
}